Michael Thomas Perone's most recent trade in Ovid Therapeutics Inc was a trade of 168,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc | Perone Thomas Michael | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 168,750 | 168,750 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Michael Thomas Perone | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 28,125 | 28,125 (0%) | 0% | 0 | Common Stock | |
| Ovid Therapeutics Inc | Thomas Michael Perone | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Thomas Michael Perone | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 25,399 | 25,399 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Thomas Michael Perone | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Thomas Michael Perone | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Thomas Michael Perone | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Thomas Michael Perone | General Counsel, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |